Category Human Rights

Internet Content Control Is Here, UN Special Rapporteur Warns IGF

“Internet content regulation is coming, in fact it is already here,” said David Kaye, United Nations special rapporteur on the promotion and protection of the right to freedom of opinion and expression, during a panel organised by the Global Network Initiative on day one of the 12th Internet Governance Forum in Geneva this week.

Intellectual Property Rights In Trade – To Be Rethought?

After two decades of intellectual property regimes in trade agreements, one could have some second thoughts, according to a number of panellists at the Trade and Sustainable Development Symposium, organised by the International Centre for Trade and Sustainable Development (ICTSD) and held alongside the 11th World Trade Organization Ministerial in Buenos Aires, Argentina this week.

G-Finder Report: Global Funding For R&D In Neglected Diseases Increasing, Overreliance On US Funding Dangerous

A report released today on global funding of research and development for neglected diseases found that global funding has increased but warns that overreliance on funding from the United States, which the report says is "unparalleled," and leads to a heavy concentration of global funding on HIV/AIDS, malaria and tuberculosis. This overreliance could also lead to change in total global funding, the report found.

WHO, World Bank Say Half The World Population Cannot Access Essential Health Services

According to a report released today by the World Health Organization and the World Bank, at least half the world's population is lacking access to essential health services. Out of pocket expenses related to health care are pushing millions of people into extreme poverty each year, the report says. Both organisations say they are committed to working with countries to increase access to essential health services.

Analysis: As Biosimilar Of Key Cancer Drug Spreads, Where Is The Price Reduction?

The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.

International Labour Organization Orders Reinstatement Of EPO Appeals Judge

In an extraordinary 6 December session, the UN International Labour Organization Administrative Tribunal (ILOAT) handed down five decisions involving the European Patent Office (EPO), one of which reinstated a suspended Board of Appeals judge. The cases are just “the tip of the iceberg,” said the Staff Union of the EPO (SUEPO).

EU-MERCOSUR FTA Puts At Risk Access To Medicines In Brazil, New Impact Assessment Study Finds

The European Union (EU) is currently negotiating a free trade agreement (FTA) with the four founding members of Mercosur (Argentina, Brazil, Paraguay and Uruguay), which comprises a chapter on intellectual property rights (IPR). A new round of negotiations is taking place from November 29th to December 8th in Brussels[1]. Word is that they aim to announce the closure of the agreement at the next World Trade Organization (WTO) Ministerial Conference that will be held from 10-13 of December in Buenos Aires and the clock is ticking to close all the chapters before that. The authors have conducted a study that shows the adoption of the measures proposed by the EU could put the sustainability of access to health policies in Brazil at risk, as they could sharply increase public expenditures on medicines.

ARIPO Adopts Plant Variety Regulations, As Farmers Advocacy Groups Raise Concern

KAMPALA, Uganda -- The Forty-first Session of the Administrative Council of African Regional Intellectual Property Organization (ARIPO) held this month adopted the Regulations for the Implementation of the Arusha Protocol for the Protection of New Varieties of Plants, amidst protest from civil society organisations and farmer representatives.

WHO Issues Two Reports Detailing Global Problem Of Substandard And Falsified Medicines

The World Health Organization today issued two substantive reports on the problem of substandard and falsified medicines around the world, finding among other things that an estimated one in 10 medical products in low and middle income countries is either substandard or falsified.